Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02886247 · ClinicalTrials.gov registry record
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
A clinical trial of Pancreatic Cancer, ATM, BRCA, Hereditary Cancer, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 12,000
- Enrollment target
- 1
- Study location
NCT02886247: Recruiting study of Pancreatic Cancer, ATM, BRCA, Hereditary Cancer, sponsored by Johns Hopkins University.
NCT02886247 is a study of Pancreatic Cancer, ATM, BRCA, Hereditary Cancer that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 12,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02886247, a study of Pancreatic Cancer, ATM, BRCA, Hereditary Cancer, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 12,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some families. Up to 10% of pancreatic cancer patients have another close relative who has also developed pancreatic cancer. This clustering of pancreatic cancers in families has yet to be explained; however, the investigators continue to identify new familial pancreatic cancer genes that explain this clustering in subsets of families. For example, in 2009 and 2012 the investigators discovered that mutations in the PALB2 and ATM genes jointly account up to 5% of the clustering of pancreatic cancer in families.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 1994-06 |
| Est. Completion | 2032-12 |
What NCT02886247 shows while recruiting
NCT02886247 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Pancreatic Cancer, ATM, BRCA, Hereditary Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02886247 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02886247 about?
NCT02886247 is a clinical study titled "Pancreatic Cancer Registry: For Any Person With a Personal or Family History". The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some fa...
What is the current status of trial NCT02886247?
This trial is currently recruiting. The enrollment target is 12,000 participants. The study started on 1994-06. Estimated completion is 2032-12.
What conditions does trial NCT02886247 study?
This clinical trial studies the following conditions: Pancreatic Cancer, ATM, BRCA, Hereditary Cancer.
Who is sponsoring clinical trial NCT02886247?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02886247 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia